share_log

Canaccord Genuity Downgrades Vicarious Surgical to Hold, Lowers Price Target to $0.4

Benzinga ·  Nov 14, 2023 06:10

Canaccord Genuity analyst Caitlin Cronin downgrades Vicarious Surgical (NYSE:RBOT) from Buy to Hold and lowers the price target from $9 to $0.4.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment